Novartis
U.S. lawmakers demand details from Novartis and AT&T about their payments to Cohen's firm.
The most innocent explanation of the payments to Michael Cohen's LLC is still pretty sketchy.
The list price will be $373,000.
The catch: It costs $475,000.
WHAT'S HAPPENING
A new cancer drug won enthusiastic support from a federal advisory panel.
A leaked Colombian Embassy memo suggests the U.S. wants to preserve the high price of cancer drug Gleevec.